UMAN ALBUMIN SOLUTION FOR INFUSION 200 G/L [SIN14044P]

Product Info

UMAN ALBUMIN SOLUTION FOR INFUSION 200 G/L

[SIN14044P]

4.1 Therapeutic indications
Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.
The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

4.2 Posology and method of administration
The concentration of the albumin preparation, dosage and infusion rate should be adjusted to the patient’s individual requirements.

Posology
The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.

If human albumin is to be administered, haemodynamic performance should be monitored regularly. This may include:

• arterial blood pressure and pulse rate

• central venous pressure

• pulmonary artery wedge pressure

• urine output

• electrolyte

• haematocrit/haemoglobin.

UMAN ALBUMIN can be administered to premature infants and dialysis patients as the aluminium content of the finished product is not more than 200 mcg/l.

Method of administration
Human albumin can be directly administered by the intravenous route, or it can also be diluted in an isotonic solution (e.g. 5% glucose or 0.9% sodium chloride).
The infusion rate should be adjusted according to the individual circumstances and the indication.
In plasma exchange, the infusion rate should be adjusted to the rate of removal.

4.3 Contraindications
Hypersensitivity to albumin preparations or to any of the excipients.